Bravo, Inc. – Trademark Portfolio
Entity Type: 03
Bravo, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include FAMIGO and RANCHO MACHO. The owner is based in Chattanooga, TN.
347 Broad Street
Chattanooga, TN 37402
Showing of trademarks Trademarks
Trademark Classifications
Bravo, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Bravo, Inc. have?
Bravo, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does Bravo, Inc. file in?
Bravo, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 29 (Meats & Processed Foods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Bravo, Inc.'s most well-known trademarks?
Bravo, Inc.'s registered trademark portfolio includes well-known marks such as FAMIGO and RANCHO MACHO. These are among 3 currently registered trademarks in the portfolio.
What is Bravo, Inc.'s trademark registration success rate?
Bravo, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.